Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Hemorrhage | 2 | 2019 | 86 | 1.160 |
Why?
|
| Tonsillectomy | 2 | 2019 | 97 | 1.080 |
Why?
|
| Vagus Nerve Stimulation | 4 | 2022 | 53 | 0.690 |
Why?
|
| Leadership | 1 | 2022 | 228 | 0.680 |
Why?
|
| Ear Canal | 1 | 2015 | 9 | 0.500 |
Why?
|
| Ear Diseases | 1 | 2015 | 18 | 0.490 |
Why?
|
| Otologic Surgical Procedures | 1 | 2015 | 23 | 0.490 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2015 | 10 | 0.490 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2015 | 28 | 0.480 |
Why?
|
| Sildenafil Citrate | 1 | 2015 | 56 | 0.480 |
Why?
|
| Lymphatic Abnormalities | 1 | 2015 | 35 | 0.470 |
Why?
|
| Internship and Residency | 2 | 2022 | 1177 | 0.470 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 68 | 0.450 |
Why?
|
| Reoperation | 2 | 2019 | 831 | 0.410 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 307 | 0.400 |
Why?
|
| Pneumonia, Aspiration | 1 | 2011 | 18 | 0.370 |
Why?
|
| Turbinates | 1 | 2010 | 12 | 0.350 |
Why?
|
| Nasal Obstruction | 1 | 2010 | 15 | 0.350 |
Why?
|
| Larynx | 1 | 2011 | 70 | 0.340 |
Why?
|
| Electrodes, Implanted | 1 | 2011 | 168 | 0.340 |
Why?
|
| Rhinoplasty | 1 | 2010 | 44 | 0.330 |
Why?
|
| Trachea | 1 | 2011 | 201 | 0.320 |
Why?
|
| Device Removal | 1 | 2011 | 223 | 0.320 |
Why?
|
| Glossectomy | 1 | 2008 | 7 | 0.320 |
Why?
|
| Macroglossia | 1 | 2008 | 2 | 0.320 |
Why?
|
| Tongue | 1 | 2008 | 29 | 0.310 |
Why?
|
| Otitis Media with Effusion | 1 | 2006 | 18 | 0.260 |
Why?
|
| Middle Ear Ventilation | 1 | 2006 | 29 | 0.250 |
Why?
|
| Lactic Acid | 1 | 2006 | 147 | 0.240 |
Why?
|
| Polymers | 1 | 2006 | 108 | 0.240 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 5125 | 0.230 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 265 | 0.210 |
Why?
|
| Child | 9 | 2019 | 24439 | 0.200 |
Why?
|
| Humans | 23 | 2022 | 124482 | 0.200 |
Why?
|
| Stroke Rehabilitation | 1 | 2022 | 59 | 0.200 |
Why?
|
| Retrospective Studies | 7 | 2019 | 16270 | 0.200 |
Why?
|
| Trust | 1 | 2022 | 75 | 0.190 |
Why?
|
| Male | 13 | 2019 | 61053 | 0.180 |
Why?
|
| Lymphangioma, Cystic | 2 | 2010 | 16 | 0.170 |
Why?
|
| Surgery, Plastic | 1 | 2022 | 111 | 0.170 |
Why?
|
| Female | 13 | 2019 | 66319 | 0.170 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 515 | 0.170 |
Why?
|
| Treatment Outcome | 7 | 2022 | 12315 | 0.150 |
Why?
|
| Adolescent | 7 | 2019 | 19301 | 0.140 |
Why?
|
| Epilepsy | 2 | 2022 | 872 | 0.130 |
Why?
|
| Suture Techniques | 1 | 2017 | 198 | 0.130 |
Why?
|
| Odontogenic Tumors | 1 | 2015 | 1 | 0.130 |
Why?
|
| Hearing Tests | 1 | 2015 | 13 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 2 | 2010 | 495 | 0.120 |
Why?
|
| Myxoma | 1 | 2015 | 29 | 0.120 |
Why?
|
| Hearing | 1 | 2015 | 52 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2013 | 128 | 0.120 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2014 | 8 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 139 | 0.120 |
Why?
|
| Mouth Abnormalities | 1 | 2014 | 15 | 0.120 |
Why?
|
| Syndactyly | 1 | 2014 | 24 | 0.120 |
Why?
|
| Maxilla | 1 | 2014 | 36 | 0.120 |
Why?
|
| Apnea | 1 | 2014 | 31 | 0.120 |
Why?
|
| Chromosome Duplication | 1 | 2015 | 147 | 0.120 |
Why?
|
| Stroke | 1 | 2022 | 977 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2021 | 997 | 0.120 |
Why?
|
| Head | 1 | 2015 | 103 | 0.120 |
Why?
|
| Fingers | 1 | 2014 | 65 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 244 | 0.110 |
Why?
|
| Mandible | 1 | 2014 | 79 | 0.110 |
Why?
|
| Neck | 1 | 2015 | 137 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2015 | 14043 | 0.110 |
Why?
|
| Eye Abnormalities | 1 | 2014 | 106 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2019 | 3066 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 20 | 0.110 |
Why?
|
| Hemangioma, Capillary | 1 | 2013 | 17 | 0.110 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 731 | 0.110 |
Why?
|
| Knee Joint | 1 | 2014 | 160 | 0.110 |
Why?
|
| Hemangiosarcoma | 1 | 2013 | 39 | 0.110 |
Why?
|
| Cleft Lip | 1 | 2014 | 125 | 0.100 |
Why?
|
| Cleft Palate | 1 | 2014 | 140 | 0.100 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2013 | 72 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 156 | 0.100 |
Why?
|
| Sirolimus | 1 | 2013 | 222 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1242 | 0.090 |
Why?
|
| Propranolol | 1 | 2011 | 128 | 0.090 |
Why?
|
| Laryngeal Neoplasms | 1 | 2011 | 79 | 0.090 |
Why?
|
| Rhinomanometry | 1 | 2010 | 2 | 0.090 |
Why?
|
| Equipment Failure | 1 | 2011 | 123 | 0.090 |
Why?
|
| Hemangioma | 1 | 2011 | 94 | 0.090 |
Why?
|
| Hypertrophy | 1 | 2010 | 102 | 0.090 |
Why?
|
| Syncope | 1 | 2010 | 52 | 0.090 |
Why?
|
| Laryngismus | 1 | 2009 | 5 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 204 | 0.080 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2009 | 39 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 530 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 964 | 0.080 |
Why?
|
| Botulinum Toxins | 1 | 2009 | 119 | 0.070 |
Why?
|
| Catheter Ablation | 1 | 2010 | 238 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1423 | 0.070 |
Why?
|
| Movement | 1 | 2008 | 170 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 376 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3575 | 0.070 |
Why?
|
| Absorbable Implants | 1 | 2006 | 23 | 0.060 |
Why?
|
| Polyesters | 1 | 2006 | 40 | 0.060 |
Why?
|
| Seizures | 1 | 2011 | 878 | 0.060 |
Why?
|
| Infant | 3 | 2015 | 12473 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2006 | 115 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 166 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2015 | 6082 | 0.060 |
Why?
|
| Hospitalization | 1 | 2011 | 1775 | 0.050 |
Why?
|
| Vagus Nerve | 1 | 2022 | 45 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 459 | 0.050 |
Why?
|
| Prognosis | 1 | 2011 | 4572 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 8970 | 0.050 |
Why?
|
| Career Choice | 1 | 2022 | 143 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2013 | 4535 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2010 | 3392 | 0.050 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 199 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 556 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 264 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2022 | 588 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2127 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2015 | 5 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2015 | 19 | 0.030 |
Why?
|
| Chromogranins | 1 | 2015 | 27 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2013 | 28 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2013 | 141 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2013 | 163 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 207 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 710 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 1064 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 1236 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 427 | 0.020 |
Why?
|
| Sclerosing Solutions | 1 | 2010 | 13 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2010 | 18 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 886 | 0.020 |
Why?
|
| Lymphatic Vessels | 1 | 2010 | 37 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 597 | 0.020 |
Why?
|
| Sclerotherapy | 1 | 2010 | 40 | 0.020 |
Why?
|
| Bleomycin | 1 | 2010 | 150 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 678 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 669 | 0.020 |
Why?
|
| Vascular Malformations | 1 | 2010 | 87 | 0.020 |
Why?
|
| Polysomnography | 1 | 2009 | 143 | 0.020 |
Why?
|
| Models, Animal | 1 | 2010 | 465 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1460 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2089 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 1218 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3338 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 4258 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2010 | 869 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 3138 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 1614 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7169 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 5805 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2014 | 8180 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 10181 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 34157 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6285 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 17736 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 19549 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 29395 | 0.010 |
Why?
|